Right Biceps Pseudo-Tumor from COVID-19 Vaccination

Author:

Abbas Anas M.1ORCID,Caicedo Martha L.2,Damron Timothy A.1ORCID

Affiliation:

1. Department of Orthopedic Surgery, SUNY Upstate Medical University, Syracuse, NY 13057, USA

2. Department of Pathology and Laboratory Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA

Abstract

Delayed hypersensitivity reactions (DHRs) have been reported in association with COVID-19 vaccines, particularly those that are mRNA-based. Classic DHRs result in induration, erythema, tenderness, and urticaria. However, soft tissue mass is an uncommon complication of a COVID-19 vaccination-associated DHR and is rarely reported in the literature. We present a case of a 49-year-old male who recognized a mildly painful, firm soft tissue mass within the biceps mimicking neoplasm six months after receiving the booster dose of the Moderna vaccine. Non-operative conservative treatment modalities, including heating pads, ice packs, acetaminophen, and ibuprofen, failed to improve the patient’s mass. The mass, which proved histologically to be an inflammatory pseudo-tumor, did not recur after complete excision. While there have been many reported cases of DHRs following COVID-19 vaccinations, we present this case to raise awareness of the development of pseudo-tumors as a possible, yet rare, clinical manifestation of DHRs following vaccination.

Funder

William Smyth Cancer Research Fund

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference24 articles.

1. US Centers for Disease Control and Prevention (2023, August 01). COVID Data Tracker: COVID-19 Vaccinations in the United States. Department of Health and Human Services, CDC, Available online: https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total.

2. Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients;Pignatti;Vaccine,2023

3. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination;Pitlick;Allergy Asthma Proc.,2022

4. Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines;Robinson;JAMA Dermatol.,2021

5. An Update in COVID-19 Vaccine Reactions in 2023: Progress and Understanding;Blumenthal;J. Allergy Clin. Immunol. Pract.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3